Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,755.17
+8.59
(+0.07%)
NZD/USD
0.6017
-0.0017
(-0.28%)
NZD/EUR
0.5583
-0.0011
(-0.19%)
ALL ORDS
8,022.70
+28.50
(+0.36%)
ASX 200
7,749.00
+27.40
(+0.35%)
OIL
79.59
+0.33
(+0.42%)
Calidi Biotherapeutics, Inc. (CLDI)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.2261
-0.0059
(-2.48%)
As of 10:23AM EDT. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
45
449
0
Cost of revenue
0
0
14
94
0
Gross profit
0
0
31
355
0
Operating expenses
Research development
13,008
13,008
7,257
4,674
3,182
Selling general and administrative
15,984
15,984
15,902
6,163
3,591
Total operating expenses
26,107
26,107
23,159
10,837
6,773
Operating income or loss
-26,107
-26,107
-23,128
-10,482
-6,773
Interest expense
1,069
1,069
158
614
163
Total other income/expenses net
656
656
-2,130
174
-997
Income before tax
-29,200
-29,200
-25,416
-10,922
-7,933
Income tax expense
16
16
11
11
4
Income from continuing operations
-29,216
-29,216
-25,427
-10,933
-7,937
Net income
-29,216
-29,216
-25,427
-10,933
-7,937
Net income available to common shareholders
-29,216
-29,216
-25,427
-10,933
-7,937
Basic EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Diluted EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Basic average shares
35,907
16,887
35,907
35,907
35,907
Diluted average shares
35,907
16,887
35,907
35,907
35,907
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.